|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:359–386. 2015.
View Article : Google Scholar
|
|
2
|
Resende LS, Rabelo-Santos SH, Sarian LO,
Alves Figueiredo RR, Ribeiro AA, Zeferino LC and Derchain S: A
porsingle and multiple HPV type infections in Brazilian women of
differentrait of t age strata with squamous or glandular cervical
lesions. BMC Infect Dis. 22:2142014. View Article : Google Scholar
|
|
3
|
Bruni 1, Barrionuevo-Rosas L, Albero G, et
al: ICO information centre on HPV and cancer (HPV Information
Centre). Human Papillomavirus Relat Dis Eur. 2017.
|
|
4
|
Zheng ZM and Baker CC: Papillomavirus
genome structure, expression, and post-transcriptional regulation.
Front Biosci. 11:2286–2302. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piyathilake CJ, Mascaluso M, Alvares RD,
Chen M, Badiga S, Edberg JC, Partridge EE and Johanning GL: A
higher degree of methylation of the HPV 16 E6 gene is associated
with a lower likelihood of being diagnosed with cervical
intraepithelial neoplasia. Cancer. 117:957–963. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balch C, Fang F, Matei DE, Huang TH and
Nephew KP: Minireview: Epigenetic changes in ovarian cancer.
Endocrinology. 150:4003–4011. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qureshi SA, Bashir MU and Yaqinuddin A:
Utility of DNA methylation markers for diagnosing cancer. Int J
Surg. 8:194–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mersakova S, Nachajova M, Szepe P,
Kasajova PS and Halasova E: DNA methylation and detection of
cervical cancer and precancerous lesions using molecular methods.
Tumour Biol. 37:23–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Murakami Y, Nobukuni T, Tamura K, Maruyama
T, Sekiya T, Arai Y, Gomyou H, Tanigami A, Ohki M, Cabin D, et al:
Localization of tumor suppressor activity important in nonsmall
cell lung carcinoma on chromosome 11q. Proc Natl Acad Sci USA.
95:8153–8158. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ando K, Ohira M, Ozaki T, Nakagawa A,
Akazawa K, Suenaga Y, Nakamura Y, Koda T, Kamijo T, Murakami Y and
Nakagawara A: Expression of TSLC1, a candidate tumor suppressor
gene mapped to chromosome 11q23, is downregulated in unfavorable
neuroblastoma without promoter hypermethylation. Int J Cancer.
123:2087–2094. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ito T, Shimada Y, Hashimoto Y, Kaganoi J,
Kan T, Watanabe G, Murakami Y and Imamura M: Involvement of TSLC1
in progression of esophageal squamous cell carcinoma. Cancer Res.
63:6320–6326. 2003.PubMed/NCBI
|
|
13
|
Mao X, Seidlitz E, Truant R, Hitt M and
Ghosh HP: Re-expression of TSLC1 in a non-small-cell lung cancer
cell line induces apoptosis and inhibits tumor growth. Oncogene.
23:5632–5642. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steenbergen RD, Kramer D, Braakhuis BJ,
Stern PL, Verheijen RH, Meijer CJ and Snijders PJ: TSLC1 gene
silencing in cervical cancer cell lines and cervical neoplasia. J
Natl Cancer Inst. 96:294–305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Overmeer RM, Henken FE, Snijders PJ,
Claassen-Kramer D, Berkhof J, Helmerhorst TJ, Heideman DA, Wilting
SM, Murakami Y, Ito A, et al: Association between dense CADM1
promoter methylation and reduced protein expression in high-grade
CIN and cervical SCC. J Pathol. 215:388–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Momparler RL and Bovenzi V: DNA
methylation and cancer. J Cell Physiol. 183:145–154. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Steenbergen RD, Snijders PJ, Heideman DA
and Meijer CH: Clinical implications of (epi) genetic changes in
HPV-induced cervical precancerous lesions. Nat Rev Cancer.
14:395–405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Overmeer RM, Louwers JA, Meijer CJ, van
Kemenade FJ, Hesselink AT, Daalmeijer NF, Wilting SM, Heideman DA,
Verheijen RH, Zaal A, et al: Combined CADM1 and MAL promoter
methylation analysis to detect (pre-)malignant cervical lesions in
high-risk HPV-positive women. Int J Cancer. 129:2218–2225. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Strooper LM, van Zummeren M,
Steenbergen RD, Bleeker MC, Hesselink AT, Wisman GB, Snijders PJ,
Heideman DA and Meijer CJ: CADM1, MAL and miR124-2methylation
analysis in cervical scrapes to detect cervical and endometrial
cancer. J Clin Pathol. 67:1067–1071. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bierkens M, Hesselink AT, Meijer CJ,
Heideman DA, Wisman GB, van der Zee AG, Snijders PJ and Steenbergen
RD: CADM1 and MAL promoter methylation levels in hrHPV-positive
cervical scrapes increase proportional to degree and duration of
underlying cervical disease. Int J Cancer. 133:1293–1299. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meršaková S, Visnovsky J, Holubekova V,
Nachajova M, Kudela E, Danko J and Lasabova Z: Detection of
methylation of the promoter region of the MAL and CADM1 genes by
pyrosequencing in cervical carcinoma. Neuro Endocrinol Lett.
35:619–623. 2014.PubMed/NCBI
|
|
22
|
Gravitt PE, Peyton CL, Alessi TQ, Wheeler
CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR and Apple RJ:
Improved amplification of genital human papillomaviruses. J Clin
Microiol. 38:357–361. 2000.
|
|
23
|
Janusicova V, Mendelova A, Zubor P,
Kapustova I, Svecova I, Kudela E, Burjanivova T, Lasabova Z and
Danko J: mRNA expression in cervical specimens for determination of
severe dysplasia or worse in HPV-16/18-positive squamous lesions. J
Low Genit Tract Dis. 18:273–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
RC Team: R: A language and environment for
statistical computing, . R foundation for statistical computing.
Vienna, Austria: URL. https://www.R-project.org/2015
|
|
25
|
Lazo PA: The molecular genetics of
cervical carcinoma. Br J Cancer. 80:2008–2018. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Doorbar J, Egawa N, Griffin H, Kranjec C
and Murakami I: Human papillomavirus molecular biology and disease
association. Rev Med Virol. 25 Suppl 1:S2–S23. 2015. View Article : Google Scholar
|
|
27
|
Kocken M, Helmerhorst TJ, Berkhof J,
Louwers JA, Nobbenhuis MA, Bais AG, Hogewoning CJ, Zaal A,
Verheijen RH, Snijders PJ and Meijer CJ: Risk of recurrent
high-grade cervical intraepithelial neoplasia after successful
treatment: A long-term multi-cohort study. Lancet Oncol.
12:441–450. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kocken M, Uijterwaal MH, de Vries AL,
Berkhof J, Ket JC, Helmerhorst TJ and Meijer CJ: High-risk human
papillomavirus testing versus cytology in predicting post-treatment
disease inwomen treated for high-grade cervical disease: A
systematic review and meta-analysis. Gynecol Oncol. 125:500–507.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hesselink AT, Heideman DA, Steenbergen RD,
Coupé VM, Overmeer RM, Rijkaart D, Berkhof J, Meijer CJ and
Snijders PJ: Combined promoter methylation analysis o CADM1 and
MAL: An obkective triage tool for high-risk human papillomavirus
DNA-positive women. Clin Cancer Res. 17:2459–2465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang HJ: Aberrant DNA methylation in
cervical carcinogenesis. Chin J Cancer. 32:42–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cushieri K, Ronco G, Lorincz A, Smith L,
Ogilvie G, Mirabello L, Carozzi F, Cubie H, Wentzensen N, Snijders
P, et al: Eurogin roadmap 2017: Triage strategies for the
management of HPV positivie women in cervical screening programs.
Int J Cancer. 143:735–745. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wentzensen N, Sherman ME, Schiffman M and
Wang SS: Utility of methylation markers in cervical cancer early
detection: Appraisal of the state-of-the-science. Gynecol Oncol.
112:293–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tornesello ML, Buonaguro L, Giorgi-Rossi P
and Buonaguro FM: Viral and cellular biomarkers in the diagnosis of
cervical intraepithelial neoplasia and cancer. Biomed Res Int.
2013:5196192013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martin-Belmonte F, Arvan P and Alonso MA:
MAL mediates apical transport of secretory proteins in polarized
epithelial Madin-Darby canine kidney cells. J Biol Chem.
276:49337–49342. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hatta M, Nagai H, Okino K, Onda M,
Yoneyama K, Ohta Y, Nakayama H, Araki T and Emi M: Down-regulation
of members of glycolipid-enriched membrane raft gene family, MAL
and BENE, in cervical squamous cell cancers. J Obstet Gynaecol Res.
30:53–58. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang W, Xie HY, Ding SM, Xing CY, Chen A,
Lai MC, Zhou L and Zheng SS: CADM1 regulates the G1/S transition
and represses tumorigenicity through the Rb-E2F pathway in
hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int.
15:289–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li X, Tao L, Tan Q, Dong Y, Pan X, Pang L,
Qi Y, Zou H, Liang W, Liu W, et al: CpG island methylation of the
CADM1 gene correlates with cervical carcinogenesis in the Uighur
and Han populations of Xinjiang, China. Int J Clin Exp Pathol.
9:6977–6987. 2016.
|
|
38
|
van Baars R, van der Marel J, Snijders PJ,
Rodriquez-Manfredi A, ter Harmsel B, van den Munckhof HA, Ordi J,
del Pino M, van de Sandt MM, Wentzensen N, et al: CADM1 and MAL
methylation status in cervical scrapes is representative of the
most severe underlying lesion in women with multiple cervical
biopsies. Int J Cancer. 138:463–471. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Uijterwaal MH, van Zummeren M, Kocken M,
Luttmer R, Berkhof J, Witte BI, van Baal WM, Graziosi GCM,
Verheijen RHM, Helmerhorst TJM, et al: Performance of
CADM1/MAL-methylation analysis for monitoring of women treated for
high-grade CIN. Gynecol Oncol. 143:135–142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ki EY, Lee KH, Hur SY, Rhee JE, Kee MK,
Kang C and Park JS: Methylation of cervical neoplastic cells
infected with human papillomavirus 16. Int J Gynecol Cancer.
26:176–183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Woo HJ, Kim SJ, Song KJ, Kim SS, Yoon CH,
Choi BS and Rhee JE: Hypermethylation of the tumor-suppressor cell
adhesion molecule 1 in human papillomavirus-transformed cervical
carcinoma cells. Int J Oncol. 46:2656–2662. 2015. View Article : Google Scholar : PubMed/NCBI
|
